10. Buprenorphine Tapering10. Buprenorphine Tapering
Addiction Medicine Journal Club
Drs. Keenan and Del Tredici explore buprenorphine tapering risks, government plans for opioid use disorder in pregnancy, and Matthew Perry's memoir.
34:42•7 Nov 2022
Buprenorphine Tapering: Risks, Research, and Real-Life Stories
“So just to summarize, being in treatment less than or Greater Than One Year did not affect the overall rate of re-entry into treatment. So if you tapered longer and slower, you had less re-entry into treatment.”
Ever wondered how tapering off buprenorphine might impact the risk of opioid overdose? In this episode of 'Addiction Medicine Journal Club', Dr. John Keenan and Dr. Sonya Del Tredici dive into a critical study that examines the prescribing characteristics associated with opioid overdose following a buprenorphine taper. They break down the nuances of taper duration, timing, and rate, providing valuable insights for both healthcare professionals and those personally affected by addiction. But that's not all.
The episode also explores the accuracy of health records for self-reported nonfatal drug and alcohol overdoses, offering a fresh perspective on data reliability in addiction medicine. Plus, you'll hear about the federal government's initiatives to support pregnant individuals with opioid use disorder, highlighting the importance of specialized care during pregnancy. As a bonus, the hosts touch on Matthew Perry's candid memoir about his journey through addiction and recovery, adding a personal touch to the scientific discussion.
With resources for safer drug use and collaborative efforts to aid primary care physicians, this episode is packed with information that's both practical and inspiring. Tune in for a thoughtful conversation that blends research, real-life stories, and actionable advice.

Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.
